PRISM MarketView

TechBio and AI Centric Recursion (RXRX) Receives IND Application for REC-1245 to Treat Solid Tumors and Lymphoma

New York, October 02, 2024 - PRISM MarketView - The PRISM NextGen Tech and AI Index and TechBio company Recursion (RXRX) is utilizing AI to decode biology and industrialize drug discovery. Today the company has announced the FDA has granted Recursion an Investigational N...

2 October 2024

Periodic Powered Nikola (NKLA) Reports Record Sales of Hydrogen Fuel Cell Class 8 Trucks, Shares Rise 10%

New York, October 02, 2024 - PRISM MarketView - In the company’s third quarter, Nikola Corporation (NKLA) has reported the sale of 88 Class 8 Nikola hydrogen fuel cell electric trucks falling in line with its guidance for the quarter and marked record quarterly sales for...

2 October 2024

Glimpse Group (VRAR) Provides a Line of Sight into Business Reports Fiscal Year 2024 Update

New York, October 01, 2024 - PRISM MarketView - Yesterday after the close the Glimpse Group (VRAR) reported its FY 2024 results. Highlights from the report included its transition to spatial core AI and Cloud Driven revenues have been gaining traction, the company is exp...

1 October 2024

Klotho Neurosciences (KLTO) Bolsters Advisory Board with Biotech Powerhouse Dr. Robert Langer, Co-Founder of Moderna

New York, September 30, 2024 - PRISM MarketView - Klotho Neurosciences, Inc. (Nasdaq: KLTO), a leader in developing therapies for neurodegenerative diseases and promoting healthy longevity, announced a pivotal milestone: Dr. Robert Langer, co-founder of Moderna, has joi...

30 September 2024

BioStem Technologies (BSEM) Takes Major Leap Towards Nasdaq Uplisting Amidst Record Revenue Growth, Targeting Enhanced Market Visibility and Global Liquidity

New York, September 30, 2024 - PRISM MarketView - BioStem Technologies (OTC: BSEM) has filed a Form 10 registration with the SEC, marking a critical step toward its planned uplisting to Nasdaq. The Company aims to be a fully reporting entity within 60 days, complying wi...

30 September 2024

BrainsWay Secures $20 Million Private Placement with Valor Equity Partners; Shares Rise 12%

New York, September 30, 2024 - PRISM MarketView - BrainsWay (NASDAQ: BWAY) has entered into a private investment financing deal with Valor Equity Partners, a firm renowned for supporting industry leaders such as SpaceX, Tesla, Neuralink, and Harmony Biosciences. This in...

30 September 2024

Real Good Food (RGF) Looks to Make Real Enhancements To Manufacturing Capacity: Announces Refinancing

New York, September 27, 2024 - PRISM MarketView - PRISM Consumer Products Index company The Real Good Food Company, Inc. (RGF) who is a prominent player in the health and wellness frozen and refrigerated foods sector, announced the amendment of its existing financing arr...

27 September 2024

Establishment Labs (ESTA) Wins FDA Approval for Motiva Implants

New York, September 27, 2024 - PRISM MarketView - Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to women’s health and wellness, has received U.S. FDA approval for its Motiva® SmoothSilk® Ergonomix® and Motiva® SmoothSilk®...

27 September 2024

Sage Therapeutics and Biogen End Collaboration on SAGE-324 Program

New York, September 26, 2024 - PRISM MarketView - Sage Therapeutics, Inc. (NASDAQ: SAGE) announced the discontinuation of its collaboration with Biogen Inc. (NASDAQ: BIIB) on the SAGE-324 program following recent negative Phase 2 trial results. Despite this, the companie...

26 September 2024

What Are the Bad Boys Going to Do? Veritone (VERI) Teams Up with Midwest Public Safety on AI-Powered Law Enforcement Platforms

New York, September 26, 2024 - PRISM MarketView - The PRISM AdTech and Media Index company Veritone, Inc. (VERI), who is a leading provider of human-centered enterprise AI solutions, has announced a new partnership with Midwest Public Safety, a top supplier of public saf...

26 September 2024